Clinical Trial Update: A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly

View source ↗

Summary

A completed study collecting feedback from patients, physicians, nurses and carers after switching to paliperidone palmitate every three months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Invega Trinza (paliperidone palmitate)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Schizophrenia | Status: COMPLETED